Skip to main content
MNKD
NASDAQ Life Sciences

CEO Michael Castagna Purchases $259,000 in Company Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.725
Mkt Cap
$839.574M
52W Low
$2.522
52W High
$6.51
52W Position info
8.1% above low
Off High info
58% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

MNKD is trading near its 52-week low of $2.522 (8.1% above the low).

Summary

MannKind's CEO, Michael Castagna, purchased $259,000 worth of common stock in an open-market transaction, demonstrating executive confidence following recent financial reports.


Key Events · Ownership and Investor Activity · MNKD

  • CEO Stock Purchase

    Michael Castagna, CEO and Director, acquired 100,000 shares of common stock for a total of $259,000 at an average price of $2.59 per share on March 10, 2026.

  • Executive Confidence Signal

    This open-market purchase by the top executive indicates strong belief in the company's value and future performance, especially following the recent Q4 and full-year 2025 earnings report on February 26, 2026.


Analysis · MNKD · Life Sciences

Michael Castagna, CEO and Director of MannKind Corporation, made a significant open-market purchase of company stock, investing $259,000. This transaction, occurring shortly after the company reported its Q4 and full-year 2025 financial results on February 26, 2026, signals strong confidence from the top executive in the company's future prospects and valuation, despite a reported decline in net income.

At the time of this filing, MNKD was trading at $2.73 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $839.6M. The 52-week trading range was $2.52 to $6.51. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MNKD - Latest Insights

MNKD
Jul 24, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.11
Real-time Price: $4.13 info
Change: +$0.020 (+0.49%) info
Market Cap: $1.276B info
MNKD
Jul 24, 2026, 6:35 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.10
Real-time Price: $4.13 info
Change: +$0.030 (+0.73%) info
Market Cap: $1.276B info
MNKD
Jul 24, 2026, 6:31 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $3.96
Real-time Price: $4.13 info
Change: +$0.170 (+4%) info
Market Cap: $1.276B info
MNKD
Jun 23, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.83
Real-time Price: $4.13 info
Change: +$0.2995 (+8%) info
Market Cap: $1.276B info
MNKD
Jun 02, 2026, 8:03 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $3.51
Real-time Price: $4.13 info
Change: +$0.620 (+18%) info
Market Cap: $1.276B info